Trials / Completed
CompletedNCT04332614
Email Campaign to Increase Uptake of myGeisinger
Email Campaign to Encourage Patients to Complete Sign-up Process for Geisinger's Patient Portal
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 14,099 (actual)
- Sponsor
- Geisinger Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 88 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the current study is to test different email messages to determine the most effect way of promoting enrollment in Geisinger's patient portal, called myGeisinger.
Detailed description
Online patient portals are convenient tools that improve patient access to healthcare services while often reducing burden to both patients and providers. However, fewer than half of patients have enrolled in Geisinger's patient portal, myGeisinger. The purpose of the current study is to assess what kind of messaging improves the effectiveness of an email campaign targeted at enrolling patients into Geisinger's online patient portal, called myGeisinger. Currently, Geisinger sends an email every month to patients who have started but not completed the enrollment process (they have had an activation code generated but have not yet used that code to enroll). This study will A/B test 5 email messages to assess if they perform better than the current standard email message. Performance will be assessed based on whether patients open the email, click on the myGeisinger enrollment link, and enroll in myGeisinger. Statistical analyses will employ generalized linear models with a binary distribution and log-link function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Less-is-better | |
| BEHAVIORAL | Social proof | |
| BEHAVIORAL | Endowment / decision staging | |
| BEHAVIORAL | Standard email |
Timeline
- Start date
- 2020-04-06
- Primary completion
- 2020-04-13
- Completion
- 2020-05-08
- First posted
- 2020-04-02
- Last updated
- 2021-05-03
- Results posted
- 2021-05-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04332614. Inclusion in this directory is not an endorsement.